Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

pharmareview.files.wordpress.com
from pharmareview.files.wordpress.com More from this publisher
02.06.2013 Views

Mucosal Oral ulceration Hair Hair – alopecia (1–10%) (1989): Kruis-de Vries MH+, Dermatologica 178, 109 (passim) (1988): Umlas J+, Cutis 42, 63 (1986): Stone MS+, JAmAcadDermatol14, 796 (passim) Other Hypersensitivity DICYCLOMINE Trade names: Antispaz; Bemote; Bentyl (Axcan); Bentylol; Byclomine; Di-Spaz; Dibent; Formulex; Lomine; Merbentyl; Neoquess; Notensyl; OrTyl; Panakiron; Spasmoban; Spasmoject; Swityl Indications: Irritable bowel syndrome Category: Anticholinergic; Muscarinic antagonist Half-life: initial: 1.8 hours; terminal: 9–10 hours Clinically important, potentially hazardous interactions with: anticholinergics, arbutamine Reactions Skin Exanthems (1987): Castleden CM+, J Clin Exp Gerontol 9, 265 Pruritus Rash (sic) (10%) Mucosal Xerostomia (>10%) Other Anaphylactoid reactions/Anaphylaxis Injection-site reactions (sic) (>10%) DIDANOSINE Trade name: Videx (Bristol-Myers Squibb) Indications: Advanced HIV infection Category: Antiretroviral; Nucleoside analog reverse transcriptase inhibitor Half-life: 1.5 hours Clinically important, potentially hazardous interactions with: acetaminophen, ciprofloxacin, corticosteroids, dapsone, itraconazole, ketoconazole, lomefloxacin, sulfones, tenofovir, tetracycline Reactions Skin Acral erythema (1993): Pedailles S+, Ann Dermatol Venereol (French) 120, 837 Diaphoresis Erythema multiforme (2001): Scully C+, Oral Dis 7(4), 205 (passim) (1992): Parneix-Spake A+, Lancet 340, 847 Exanthems Pruritus (9%) Purpura Rash (sic) (9%) Stevens–Johnson syndrome (2003): Rotunda A+, Acta Derm Venereol 83(1), 1 (1992): Parneix-Spake A+, Lancet 340, 847 Urticaria Vasculitis (1994): Herranz P+, Lancet 344, 680 Mucosal Xerostomia (2001): Scully C+, Oral Dis 7(4), 205 (up to 33%) (passim) (1993): Allan JD+, Clin Infect Dis 16 Suppl 1, S46 (1992): Dodd CL+, Lancet 340(8822), 790 (1992): Valentine C+, Lancet 340(8834–8835), 1542 Hair Hair – alopecia (

178 DIETHYLPROPION Erythema (

Mucosal<br />

Oral ulceration<br />

Hair<br />

Hair – alopecia (1–10%)<br />

(1989): Kruis-de Vries MH+, Dermatologica 178, 109 (passim)<br />

(1988): Umlas J+, Cutis 42, 63<br />

(1986): Stone MS+, JAmAcadDermatol14, 796 (passim)<br />

Other<br />

Hypersensitivity<br />

DICYCLOMINE<br />

Trade names: Antispaz; Bemote; Bentyl (Axcan); Bentylol;<br />

Byclomine; Di-Spaz; Dibent; Formulex; Lomine; Merbentyl;<br />

Neoquess; Notensyl; OrTyl; Panakiron; Spasmoban; Spasmoject;<br />

Swityl<br />

Indications: Irritable bowel syndrome<br />

Category: Anticholinergic; Muscarinic antagonist<br />

Half-life: initial: 1.8 hours; terminal: 9–10 hours<br />

Clinically important, potentially hazardous interactions<br />

with: anticholinergics, arbutamine<br />

Reactions<br />

Skin<br />

Exanthems<br />

(1987): Castleden CM+, J Clin Exp Gerontol 9, 265<br />

Pruritus<br />

Rash (sic) (10%)<br />

Mucosal<br />

Xerostomia (>10%)<br />

Other<br />

Anaphylactoid reactions/Anaphylaxis<br />

Injection-site reactions (sic) (>10%)<br />

DIDANOSINE<br />

Trade name: Videx (Bristol-Myers Squibb)<br />

Indications: Advanced HIV infection<br />

Category: Antiretroviral; Nucleoside analog reverse<br />

transcriptase inhibitor<br />

Half-life: 1.5 hours<br />

Clinically important, potentially hazardous interactions<br />

with: acetaminophen, ciprofloxacin, corticosteroids, dapsone,<br />

itraconazole, ketoconazole, lomefloxacin, sulfones, tenofovir,<br />

tetracycline<br />

Reactions<br />

Skin<br />

Acral erythema<br />

(1993): Pedailles S+, Ann Dermatol Venereol (French) 120, 837<br />

Diaphoresis<br />

Erythema multiforme<br />

(2001): Scully C+, Oral Dis 7(4), 205 (passim)<br />

(1992): Parneix-Spake A+, Lancet 340, 847<br />

Exanthems<br />

Pruritus (9%)<br />

Purpura<br />

Rash (sic) (9%)<br />

Stevens–Johnson syndrome<br />

(2003): Rotunda A+, Acta Derm Venereol 83(1), 1<br />

(1992): Parneix-Spake A+, Lancet 340, 847<br />

Urticaria<br />

Vasculitis<br />

(1994): Herranz P+, Lancet 344, 680<br />

Mucosal<br />

Xerostomia<br />

(2001): Scully C+, Oral Dis 7(4), 205 (up to 33%) (passim)<br />

(1993): Allan JD+, Clin Infect Dis 16 Suppl 1, S46<br />

(1992): Dodd CL+, Lancet 340(8822), 790<br />

(1992): Valentine C+, Lancet 340(8834–8835), 1542<br />

Hair<br />

Hair – alopecia (

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!